Imaging Flow Cytometer combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery and functional insights of microscopy. This unique combination enables a broad range of applications that would be impossible using either technique alone.
Government of developed and developing countries is spending high on drug discovery. Increasing number of clinical trials each year and rapid advancements in electronic devices for cellular analysis are major factors expected to drive the growth of global image-based cytometer market. More than 18,000 clinical trials are actively recruiting patients in the U.S. As of February 1, 2021, there were around 366 thousand clinical studies registered globally. The number of clinical studies has increased significantly since there were just 2,119 registered in 2000. With the chancing healthcare landscape development in laboratory devices is gaining traction. Increasing number of patients suffering from chronic diseases and focus towards minimizing the turn-around time on test samples. Flow cytometers can be used to study viruses and viral particles due to the high sensitivity of time-delayed integration (TDI) and CCD camera technology. Rising pandemic effect across the globe, high investment by the government for vaccine development and increasing use of imaging flow cytometer for R&D activities are factors expected to augment the growth of image-based cytometer market. Imaging flow cytometer provides high performance in a small package. Its design increases signal and minimizes noise to provide unmatched fluorescence sensitivity. Major players are investing high for product development their approach towards enhancing the customer base is expected to boost the image-based cytometer market growth.
In 2021, Beckman Coulter Life Sciences, a global medical devices manufacturer launched “CytoFLEX SRT Benchtop Cell Sorter”. The product launch is expected to help the company to enhance the business and increase the product offerings.
In 2016, Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry launched “Celigo image cytometer”. The product is a benchtop image cytometry system providing whole-well imaging and quantitative data, through image analysis for demanding cell-based analytical applications. This product launched helped the company to enhance the business and increase the revenue share.
Favorable business policies by the government and major players approach towards enhancing the business in emerging economies are factors expected to support the target market growth. Factors such as high cost of devices and technological glitches are expected to hamper the growth of global image-based cytometer market. In addition, stringent government regulations related to product approval is expected to challenge the growth of the target market. However, increasing government spending on development of present infrastructure and high investment by major players for product development are factors expected to create new opportunities for players operating in the image-based cytometer market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of the target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global image-based cytometer market due to high spending on drug development. Increasing investment by major players for introduction of innovative products and rise in clinical trials each year is expected to support the image-based cytometer market growth. Increasing merger and acquisition activities in order to enhance the product offering and increase the business is expected to boost the regional growth.
The global image-based cytometer market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Image-Based Cytometer Market Segment Analysis, 2019
The global image-based cytometer market is segmented into application and end use. The application segment is divided into research, clinical, and others. Among application the research segment is expected to account for major revenue share in the global image-based cytometer market. The end use segment is bifurcated into hospital, commercial organizations, clinical testing labs, and others. The players profiled in the report are Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation and Thorlabs, Inc.
Market By Application
Market By End Use
Clinical Testing Labs
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Government of developed and developing countries is spending high on drug discovery. Increasing number of clinical trials each year and rapid advancements in electronic devices for cellular analysis are major factors expected to drive the growth of global image-based cytometer market.
In application the research segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are GE Healthcare, PerkinElmer, Inc., Merck Millipore, Thermo Fisher Scientific, Inc., and Li-Cor Biosciences.
The North America is expected to account for major revenue share in the global market.
In end use the clinical testing labs segment is growing at faster pace.
Factors such as high cost of devices and technological glitches are expected to hamper the growth of global image-based cytometer market.